Skip to main content

Health

‘Don’t feel like a guinea pig:’ New COVID-19 vaccine is safe, effective

Although it may seem that the COVID-19 vaccine came from out of nowhere, it underwent the same rigorous testing that all vaccines do. Ivan Martinez—a virologist with the WVU School of Medicine and Cancer Institute—discusses how the vaccine was made, why it’s safe, and how it will make our lives better in 2021.

WVU researchers inform COVID-19 vaccine communication

The first shipments of the Pfizer COVID-19 vaccine arrived in West Virginia on December 14. As doses are administered, researchers from the West Virginia University Public Interest Communication Research Lab are focused on making sure West Virginians get timely, accurate and scientifically sound information related to the vaccine.

WVU graduates encouraged to celebrate resilience, game-changing milestones

Not only do West Virginia University’s newest graduates have much to celebrate in a year that defied traditions and norms, as they enter the next phase of their lives, they are drawing strength from being tested and are instilled with the most critical skills for succeeding in the 21st century: adaptability, resilience and purpose.

‘No such thing as a little bit of pain:’ More cancer patients could benefit from rehabilitation, WVU researcher says

Cancer treatment isn’t just a matter of shrinking or removing a tumor. It also involves preserving or improving the patient’s quality of life. Rehabilitation services—such as behavioral therapies to alleviate pain and exercise to reduce fatigue—are a valuable way to do that. But they often aren’t included in cancer patients’ plans of care.

Donor-funded research position curbs disease associated with opioid epidemic

As West Virginia became the epicenter of the nation’s opioid epidemic, donor dollars brought Dr. Judith Feinberg to the West Virginia University School of Medicine to expand research focused on the intersection of addiction and infectious disease. More than five years later, her work is making a difference by expanding testing and increasing access to treatments for diseases spread through injection drug use – HIV, hepatitis B and hepatitis C.

Virtual therapy: The ‘new normal’ after COVID-19

Once the COVID-19 pandemic is over, a lot of things will go back to normal. We’ll stop wearing masks. We’ll crowd into restaurants. We’ll walk whatever direction we want to down grocery store aisles. But some changes that the pandemic spurred might be here to stay. Among them: the expansion of telepsychiatry.